Home › Companies › Aquestive Therapeutics, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Aquestive Therapeutics, Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 10, 2026: 4 items on Aquestive Therapeutics, Inc.’s Form 8-K, filed June 10, 2026: 2 approved · 2 without a stated outcome.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Aquestive Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Aquestive Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: John S. Cochran | 36,914,899 | -- | 5,680,845 | -- | -- | — | Not verified | — |
| Elect Director: Abigail L. Jenkins | 39,094,166 | -- | 3,501,578 | -- | -- | — | Not verified | — |
| 2. Proposal to approve, on a non-binding advisory basis, executive compensation | 37,798,609 | 3,192,381 | 1,604,754 | -- | 37,465,582 | 92% | Approved | — |
| 3. Appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 | 78,804,323 | 910,690 | 346,313 | -- | -- | 99% | Approved | — |
Source: Aquestive Therapeutics, Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
163 asset managers disclosed a vote on at least one Aquestive Therapeutics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Aquestive Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
97% of fund votes cast · no official result
Description as filed by funds: To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Abigail L. Jenkins
The 27 asset managers below reported 4,975,620 for, 150,113 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,271,297 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 856,623 | 0 | 0 | 0 | For |
| Fidelity | 638,919 | 0 | 0 | 0 | For |
| Equitable | 29,379 | 0 | 0 | 53,980 | Mixed |
| State Street | 80,392 | 0 | 0 | 59 | For |
| Lincoln Financial | 64,000 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 28,350 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 15,722 | Withhold |
| AQR | 0 | 0 | 0 | 15,077 | Withhold |
| DWS | 0 | 0 | 0 | 14,058 | Withhold |
| Pacific Life | 12,053 | 0 | 0 | 0 | For |
| Voya | 9,501 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 7,276 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 5,200 | Withhold |
| Principal | 0 | 0 | 0 | 5,060 | Withhold |
| Goldman Sachs | 4,641 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 0 | 4,028 | Withhold |
| PENN SERIES FUNDS INC | 2,800 | 0 | 0 | 0 | For |
| TIAA | 2,287 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,165 | 0 | 0 | 0 | For |
| Nationwide | 1,332 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 785 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 308 | Withhold |
| Victory Capital | 0 | 0 | 0 | 208 | Withhold |
| T. Rowe Price | 134 | 0 | 0 | 0 | For |
Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Gregory B. Brown, M.D.
The 27 asset managers below reported 5,118,421 for, 7,312 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,271,297 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 856,623 | 0 | 0 | 0 | For |
| Fidelity | 638,919 | 0 | 0 | 0 | For |
| Equitable | 83,359 | 0 | 0 | 0 | For |
| State Street | 80,415 | 0 | 0 | 36 | For |
| Lincoln Financial | 64,000 | 0 | 0 | 0 | For |
| ProShares | 28,350 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 15,722 | 0 | 0 | 0 | For |
| AQR | 15,077 | 0 | 0 | 0 | For |
| DWS | 14,058 | 0 | 0 | 0 | For |
| Pacific Life | 12,053 | 0 | 0 | 0 | For |
| Voya | 9,501 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 7,276 | Withhold |
| Blackstone Alternative Investment Funds | 5,200 | 0 | 0 | 0 | For |
| Principal | 5,060 | 0 | 0 | 0 | For |
| Goldman Sachs | 4,641 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,028 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 2,800 | 0 | 0 | 0 | For |
| TIAA | 2,287 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,165 | 0 | 0 | 0 | For |
| Nationwide | 1,332 | 0 | 0 | 0 | For |
| Guggenheim | 785 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 308 | 0 | 0 | 0 | For |
| Victory Capital | 208 | 0 | 0 | 0 | For |
| T. Rowe Price | 134 | 0 | 0 | 0 | For |
Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).
80% of fund votes cast · no official result
Description as filed by funds: To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: John S. Cochran
The 27 asset managers below reported 4,109,472 for, 1,016,261 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,271,297 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 0 | 0 | 0 | 856,623 | Withhold |
| Fidelity | 638,919 | 0 | 0 | 0 | For |
| Equitable | 29,379 | 0 | 0 | 53,980 | Mixed |
| State Street | 80,368 | 0 | 0 | 83 | For |
| Lincoln Financial | 64,000 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 28,350 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 15,722 | Withhold |
| AQR | 0 | 0 | 0 | 15,077 | Withhold |
| DWS | 0 | 0 | 0 | 14,058 | Withhold |
| Pacific Life | 12,053 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 9,501 | Withhold |
| Calvert | 0 | 0 | 0 | 7,276 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 5,200 | Withhold |
| Principal | 0 | 0 | 0 | 5,060 | Withhold |
| Goldman Sachs | 4,641 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 0 | 4,028 | Withhold |
| PENN SERIES FUNDS INC | 2,800 | 0 | 0 | 0 | For |
| TIAA | 2,287 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,165 | 0 | 0 | 0 | For |
| Nationwide | 1,332 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 785 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 308 | Withhold |
| Victory Capital | 0 | 0 | 0 | 208 | Withhold |
| T. Rowe Price | 134 | 0 | 0 | 0 | For |
Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: Elect Abigail Jenkins
The 15 asset managers below reported 2,672,932 for, 2,720 withheld, 571 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,020,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 723,482 | 0 | 0 | 0 | For |
| Charles Schwab | 267,401 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 234,279 | 0 | 0 | 0 | For |
| Federated Hermes | 156,350 | 0 | 0 | 0 | For |
| Russell Investments | 97,519 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,940 | 0 | 0 | 0 | For |
| Global X | 48,259 | 0 | 0 | 0 | For |
| SEI | 15,400 | 0 | 0 | 0 | For |
| Vanguard | 11,473 | 0 | 10 | 0 | For |
| Venerable Variable Insurance Trust | 7,126 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 0 | 0 | 0 | 2,720 | Withhold |
| Nationwide | 2,301 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 567 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 561 | 0 | Abstain |
Combines 5 wordings of this item as funds reported it.
99.7% of fund votes cast · no official result
The 15 asset managers below reported 2,668,020 for, 8,200 withheld, 3 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,020,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 723,482 | 0 | 0 | 0 | For |
| Charles Schwab | 267,401 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 234,279 | 0 | 0 | 0 | For |
| Federated Hermes | 156,350 | 0 | 0 | 0 | For |
| Russell Investments | 97,519 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,940 | 0 | 0 | 0 | For |
| Global X | 48,259 | 0 | 0 | 0 | For |
| SEI | 15,400 | 0 | 0 | 0 | For |
| Vanguard | 3,847 | 0 | 3 | 7,633 | Mixed |
| Venerable Variable Insurance Trust | 7,126 | 0 | 0 | 0 | For |
| Eleva Capital SAS | 2,720 | 0 | 0 | 0 | For |
| Nationwide | 2,301 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 567 | Withhold |
| John Hancock | 561 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
93% of fund votes cast · no official result
Description as filed by funds: Elect John S. Cochran
The 15 asset managers below reported 2,496,428 for, 179,224 withheld, 571 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,020,835 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 723,482 | 0 | 0 | 0 | For |
| Charles Schwab | 267,401 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 234,279 | 0 | 0 | 0 | For |
| Federated Hermes | 156,350 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 0 | 97,519 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 87,940 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 48,259 | Withhold |
| SEI | 0 | 0 | 0 | 15,400 | Withhold |
| Vanguard | 3,840 | 0 | 10 | 7,633 | Mixed |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 7,126 | Withhold |
| Eleva Capital SAS | 0 | 0 | 0 | 2,720 | Withhold |
| Nationwide | 2,301 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 567 | Withhold |
| John Hancock | 0 | 0 | 561 | 0 | Abstain |
Combines 7 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Aquestive Therapeutics, Inc.’s own tally for this item (“2. Proposal to approve, on a non-binding advisory basis, executive compensation”): 37,798,609 for, 3,192,381 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The proposal to approve, on a non-binding advisory basis, executive compensation was approved for the one year.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,282,769 | 7 | 4 | 0 | For |
| BlackRock | 1,020,835 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 856,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 723,482 | 0 | 0 | 0 | For |
| Fidelity | 638,919 | 0 | 0 | 0 | For |
| Charles Schwab | 267,401 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 234,279 | 0 | 0 | 0 | For |
| Federated Hermes | 156,350 | 0 | 0 | 0 | For |
| Russell Investments | 97,519 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,940 | 0 | 0 | 0 | For |
| Equitable | 83,359 | 0 | 0 | 0 | For |
| State Street | 80,449 | 2 | 0 | 0 | For |
| Lincoln Financial | 64,000 | 0 | 0 | 0 | For |
| Global X | 48,259 | 0 | 0 | 0 | For |
| ProShares | 28,350 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 15,722 | 0 | 0 | 0 | For |
| SEI | 15,400 | 0 | 0 | 0 | For |
| AQR | 15,077 | 0 | 0 | 0 | For |
| DWS | 14,058 | 0 | 0 | 0 | For |
| Pacific Life | 12,053 | 0 | 0 | 0 | For |
| Voya | 9,501 | 0 | 0 | 0 | For |
| Calvert | 7,276 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 7,126 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 5,200 | 0 | 0 | 0 | For |
| Principal | 5,060 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,799,125 for, 106 against, 4 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 7,426,471 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 2,500,000 | 0 | 0 | 0 | For |
| BlackRock | 1,487,261 | 41,501 | 1,269 | 0 | For |
| Blue Owl Capital Holdings LP | 1,207,932 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 1,088,110 | 0 | 0 | 0 | For |
| Federated Hermes | 939,608 | 0 | 0 | 0 | For |
| State Street | 925,306 | 4,188 | 0 | 0 | For |
| WASATCH ADVISORS LP | 877,289 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 757,139 | 0 | 0 | 0 | For |
| Two Sigma | 688,491 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 659,772 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 550,915 | 0 | 0 | 0 | For |
| Bracebridge Capital, LLC | 459,216 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 385,562 | 0 | 0 | 0 | For |
| Northern Trust | 369,141 | 0 | 0 | 0 | For |
| Charles Schwab | 267,419 | 0 | 0 | 0 | For |
| Latash Investments, LLC | 243,134 | 0 | 0 | 0 | For |
| Wellington | 207,255 | 0 | 0 | 0 | For |
| Russell Investments | 193,146 | 0 | 0 | 0 | For |
| Vanguard | 170,991 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 128,696 | 0 | 0 | 0 | For |
| Citadel | 110,193 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 99,086 | 0 | 0 | 0 | For |
| Bleakley Financial Group, LLC | 92,358 | 0 | 0 | 0 | For |
| Sanctuary Advisors, LLC | 87,969 | 0 | 0 | 0 | For |
Institutional-manager reports, all 136 managers: 23,068,945 for, 100,433 against, 1,446 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Aquestive Therapeutics, Inc.’s own tally for this item (“3. Appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026”): 78,804,323 for, 910,690 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 7,799,462 for, 2,495 against, 1,000 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,280,298 | 2,483 | 0 | 0 | For |
| BlackRock | 1,020,835 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 856,623 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 723,482 | 0 | 0 | 0 | For |
| Fidelity | 638,919 | 0 | 0 | 0 | For |
| Charles Schwab | 267,401 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 234,279 | 0 | 0 | 0 | For |
| Federated Hermes | 156,350 | 0 | 0 | 0 | For |
| Russell Investments | 97,519 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,940 | 0 | 0 | 0 | For |
| Equitable | 83,359 | 0 | 0 | 0 | For |
| State Street | 80,439 | 12 | 0 | 0 | For |
| Lincoln Financial | 64,000 | 0 | 0 | 0 | For |
| Global X | 48,259 | 0 | 0 | 0 | For |
| ProShares | 28,350 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 15,722 | 0 | 0 | 0 | For |
| SEI | 15,400 | 0 | 0 | 0 | For |
| AQR | 15,077 | 0 | 0 | 0 | For |
| DWS | 14,058 | 0 | 0 | 0 | For |
| Pacific Life | 12,053 | 0 | 0 | 0 | For |
| Voya | 9,501 | 0 | 0 | 0 | For |
| Calvert | 7,276 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 7,126 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 5,200 | 0 | 0 | 0 | For |
| Principal | 5,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 125,450,119 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.62% |
| 2 | BlackRock | 0.81% |
| 3 | WASATCH FUNDS TRUST | 0.68% |
| 4 | Bridge Builder Trust | 0.58% |
| 5 | Fidelity | 0.51% |
| 6 | Charles Schwab | 0.21% |
| 7 | Simplify Exchange Traded Funds | 0.19% |
| 8 | Federated Hermes | 0.12% |
| 9 | Russell Investments | 0.08% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.07% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RTW INVESTMENTS, LP | 5.92% |
| 2 | Samsara BioCapital, LLC | 1.99% |
| 3 | BlackRock | 1.22% |
| 4 | Blue Owl Capital Holdings LP | 0.96% |
| 5 | Janney Montgomery Scott LLC | 0.87% |
| 6 | Federated Hermes | 0.75% |
| 7 | State Street | 0.74% |
| 8 | WASATCH ADVISORS LP | 0.70% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.60% |
| 10 | Two Sigma | 0.55% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Douglas K. Bratton | 9,858,384 | 7.86% | Proxy statement (DEF 14A), table as of April 2, 2026 |
| BlackRock | 7,509,071 | 5.99% | Form 13F, quarter ended March 31, 2026 |
| RTW Investments, LP | 6,250,000 | 4.98% | Proxy statement (DEF 14A), table as of April 2, 2026 |
| Vanguard Group | 5,892,334 | 4.70% | Form 13F, quarter ended March 31, 2026 |
| MonoLine RX II, L.P. | 3,468,747 | 2.77% | Proxy statement (DEF 14A), table as of April 2, 2026 |
| Daniel Barber | 3,068,727 | 2.45% | Proxy statement (DEF 14A), table as of April 2, 2026 |
| MonoLine RX III, L.P. | 2,657,943 | 2.12% | Proxy statement (DEF 14A), table as of April 2, 2026 |
| State Street | 2,546,191 | 2.03% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 2,408,191 | 1.92% | Form 13F, quarter ended March 31, 2026 |
| MonoLine Partners, L.P. | 1,783,578 | 1.42% | Proxy statement (DEF 14A), table as of April 2, 2026 |
Percentages above are of 125,450,119 shares outstanding, as reported by Aquestive Therapeutics, Inc. on its Form 10-Q dated May 11, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Aquestive Therapeutics, Inc.'s shareholder meeting held June 10, 2026, in the 2025-2026 proxy season, 163 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 766 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — Aquestive Therapeutics, Inc.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Aquestive Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Aquestive Therapeutics, Inc.’s 10-Q dated May 11, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Aquestive Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Aquestive Therapeutics (AQST) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/aquestive-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.